Back to News
Market Impact: 0.1
AngioDynamics Names Jacobi Hospital As ALPHA-PE Research Fund Recipient
Source: Nasdaq
Healthcare & BiotechCompany Fundamentals
AngioDynamics announced that New York's Jacobi Hospital was selected as a recipient of an ALPHA-PE Research Fund award. The announcement supports research activity around the company's vascular and cancer-treatment technologies, but disclosed no financial terms or expected earnings impact.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
ANGO0.40
More News
- Anthropic warns government attitudes may hurt customer ties, IPO prospectus shows: Reuters
- Your health insurance premiums may take a big jump in 2027 — here's why
- Paramount and Warner Bros. Discovery to Merge Into Skydance (SKYD). Will Skydance Achieve David Ellison’s "Quality Storytelling" Vision?
- Big Pharma turns to China for new drugs as patent cliff drives multibillion-dollar deals
- Why Lilly and Novo are betting on amylin to power a new wave of obesity drugs after GLP-1s
- Tesla reports 486,532 vehicle deliveries for third quarter, topping expectation